We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lupin Fires Back At Novartis In Lotrel Patent Spat

Law360 (November 5, 2007, 12:00 AM EST) -- Indian generics giant Lupin Ltd. filed counterclaims Monday in a suit over Lotrel, saying Novartis Corp. deceived the U.S. Patent and Trademark Office into issuing the patent to the billion-dollar hypertension...
To view the full article, register now.